A prospective cohort study identifies two types of HIV+ Kaposi Sarcoma (KS) lesions: proliferative and inflammatory
Targeted human RNAseq performed on KS skin lesion biopsies from HIV+ participants before treatment with chemotherapy-one biopsy per participant. Participants may or may not have been on combination antiretroviral therapy for HIV. All lesions were of severity to require chemotherapy.